The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults

Coming Soon.

Year: 2022

Reference: Aljumaah, M. R., Bhatia, U., Roach, J., Gunstad, J., & Azcarate Peril, M. A. (2022). The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults. Clinical nutrition (Edinburgh, Scotland), 41(11), 2565–2576. https://doi.org/10.1016/j.clnu.2022.09.012

Related Studies

The role of gut microbiota in anxiety, depression, and other mental disorders as well as the protective effects of dietary components

The proportion of the population that suffers from mental disorders (anxiety and depression, among others) has risen dramatically in the last few years. As a result, finding preventative and treatment methods for mental illnesses is crucial. Several gut microbiota strains, particularly Bacteroidetes, and Firmicutes, have been shown to influence mental health via the microbiota gut-brain […]

Effect of nutritional supplements on gut microbiome in individuals with neurodevelopmental disorders: a systematic review and narrative synthesis

A wide range of illnesses known as neurodevelopmental disorders (NDDs) are distinguished by disruptive symptoms, variable prevalence rates, and several contributing variables. Recent research suggests a potential link between NDDs and the gut-brain axis. Other research suggests that dietary supplements may affect behavioral and gastrointestinal (GI) problems. This study by Dehghani et al. (2025) looks […]